Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin

Alyssa Shell Tilhou, Jen Birstler, Amelia Baltes, Elizabeth Salisbury‐Afshar, Julia Malicki, Guanhua Chen, Randall BrownHarm 2022 · DOI

Abstract: We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.

Introduction

The United States is currently navigating a "third wave" of the opioid crisis, characterized by the widespread adulteration of the illicit drug supply with potent synthetic opioids, primarily fentanyl. Fentanyl test strips (FTS) have emerged as a vital, low-cost harm reduction tool. However, their effectiveness depends on successful implementation and consistent utilization by people who use drugs (PWUD). This study, conducted in southern Wisconsin, explores the situational, logistical, and psychosocial factors that influence FTS uptake among syringe service program (SSP) clients.

Methods

The researchers employed a sequential exploratory mixed-methods design, known as the SAFeR study. Phase 1 involved qualitative, semi-structured interviews with 29 PWUD to identify community-specific concerns and refine survey language. Phase 2 consisted of a structured survey administered to 341 clients across four SSP sites in Wisconsin: Beloit, Kenosha, Madison, and Milwaukee. Data analysis included bivariate tests and multivariable logistic regression to identify characteristics associated with FTS use.

Participant Characteristics and Disparities

The study sample was predominantly male (59.6%) and non-Hispanic white (77.4%), with a mean age of 35.7 years. A significant majority (87.9%) reported intravenous drug use. Analysis revealed notable disparities in FTS utilization. Non-Hispanic white respondents were significantly more likely to use FTS than non-Hispanic Black or African American respondents (p=0.006 in multivariable models). Additionally, FTS use was more prevalent in urban centers like Milwaukee and Madison compared to sites in Kenosha and Beloit.

Demographic and drug use characteristics of survey participants, highlighting significant differences in FTS use by site and race.

The Reality of the Drug Supply: Intentionality and Saturation

A critical finding of the study is the shift in how fentanyl is perceived within the community. Contrary to the traditional narrative that FTS are used primarily to avoid fentanyl, approximately 70% of respondents reported intentionally seeking drugs that contain fentanyl. For these individuals, FTS serve as a tool to confirm potency or manage dosage rather than a means of avoidance.

This intentional use occurs within a heavily saturated market. Among FTS users, 80.6% reported receiving a positive result "half the time" or more, confirming that fentanyl is nearly ubiquitous in the local illicit drug supply.

FTS Use Patterns and the Stimulant Blind Spot

While FTS uptake is high among heroin users (92.7%), the study identified a dangerous "blind spot" among stimulant users. Testing rates for cocaine (27.0%), crack cocaine (32.1%), and methamphetamine (19.0%) were significantly lower. This suggests a lack of awareness regarding the penetration of fentanyl into the stimulant supply, leaving these populations at high risk for accidental overdose.

Reported behaviors and outcomes related to fentanyl test strip (FTS) use, including frequency of testing and specific drugs tested.

Furthermore, consistent testing remains a challenge; only 36.5% of FTS users reported testing "most of the time" or "every time." Nearly 30% of users reported confusion over interpreting test results, highlighting a need for better education alongside distribution.

Barriers to Utilization

Qualitative interviews identified the perception of "wasting drugs" as a major psychosocial barrier. Many PWUD believe that testing requires sacrificing a usable portion of their supply. Correcting this misconception—by emphasizing that residue in a cooker or baggie is sufficient for testing—is a priority for increasing uptake. Logistical hurdles, such as lack of transportation and the absence of a safe, private place to use, also negatively impacted testing consistency.

Conclusions and Implications

The findings necessitate a shift in harm reduction messaging. Programs should move beyond simple "avoidance" narratives toward "informed use" and the promotion of adjunct safety behaviors, such as carrying naloxone and never using alone. To address identified disparities, FTS distribution should expand beyond traditional SSPs to include pharmacies, health departments, and community centers, ensuring broader and more equitable access for all populations at risk.

Summary updated

Abstract

We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.
BibTeX
@inproceedings{tilhou2022characteristics,
  author = {Alyssa Shell Tilhou and Jen Birstler and Amelia Baltes and Elizabeth Salisbury‐Afshar and Julia Malicki and Guanhua Chen and Randall Brown},
  title = {{Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin}},
  booktitle = {Harm},
  year = {2022},
  doi = {10.1186/s12954-022-00720-7},
}
Figure